Ascend Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-449,390
| Closed | -$8.52M | – | 268 |
|
2017
Q4 | $8.52M | Buy |
+449,390
| New | +$8.52M | 0.32% | 87 |
|
2016
Q1 | – | Sell |
-357,991
| Closed | -$23.5M | – | 144 |
|
2015
Q4 | $23.5M | Buy |
+357,991
| New | +$23.5M | 0.83% | 37 |
|
2015
Q3 | – | Sell |
-505,119
| Closed | -$29.9M | – | 160 |
|
2015
Q2 | $29.9M | Buy |
505,119
+102,269
| +25% | +$6.04M | 0.98% | 37 |
|
2015
Q1 | $25.1M | Buy |
+402,850
| New | +$25.1M | 0.86% | 37 |
|
2014
Q3 | – | Sell |
-125,515
| Closed | -$6.58M | – | 211 |
|
2014
Q2 | $6.58M | Sell |
125,515
-211,485
| -63% | -$11.1M | 0.22% | 116 |
|
2014
Q1 | $17.8M | Sell |
337,000
-1,638,045
| -83% | -$86.6M | 0.46% | 66 |
|
2013
Q4 | $79.2M | Buy |
+1,975,045
| New | +$79.2M | 2.41% | 5 |
|
2013
Q3 | – | Sell |
-43,696
| Closed | -$1.71M | – | 236 |
|
2013
Q2 | $1.71M | Buy |
+43,696
| New | +$1.71M | 0.07% | 152 |
|